CF shortlisted as Consultancy of the Year in the LaingBuisson 2024 awards
LaingBuisson has announced finalists for its 2024 awards, and [...]
Investing in the Dementia Age
Dementia is the UK’s number one killer and the [...]
Improving market access of medicines in the UK – Our view in 2024
Addressing access and adoption of medicines in the UK [...]
FDA Guidance: Using EHRs and Medical Claims Data to support drug and biological products regulation
The FDA has published guidance as part of its [...]
The 2024 King’s Speech
The King’s Speech is part of the State Opening [...]
CF named as strategic consultants of the year at the 2024 HealthInvestor Awards
We’re thrilled to announce that we have won ‘Strategic [...]
The economic and healthcare cost of dementia
Dementia Action Week is an annual awareness raising campaign [...]
CF receives Chartered Management Consultant (ChMC) Accreditation
We are delighted to announce that CF has received [...]
Multiple Sclerosis in England
Multiple Sclerosis Awareness Week 2024 runs from the 22nd [...]
Improving translation of digital health technologies (DHTs) from academia
CF recently completed a research [...]
